FDA recall, , Low risk
CVS Pharmacy Lidocaine Wound Gel
Lidocaine Wound Gel failed pH specifications.
Summary by Recall Canary from the FDA notice
What happened
Water-Jel Technologies, LLC of Huntersville, North Carolina recalled Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), distributed by CVS Pharmacy, Inc., because it failed pH specifications. The recall began April 7, 2026, and was added to the FDA's Enforcement Report on April 30, 2026. The product was distributed nationwide in the USA.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Lidocaine Wound Gel
- NDC
- 59898-950
- Lot code
- A5014
- A5018
- A5019
Recall details
- Company began the recall
- Sold in
Nationwide in the USA
- Company
- Water-Jel Technologies, LLCHuntersville, North Carolina
- Hazard
- Quality testing problem
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 98737
- Recall number
- D-0509-2026
- Quantity recalled
- 31,488 tubes
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
